BackRadiopharm Theranostics Limited Overview

Radiopharm Theranostics Limited Total Current Liabilities

Track Radiopharm Theranostics Limited's total current liabilities ($19M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Total Current Liabilities
$18.90M

Peer trimmed avg / median

Loading

Radiopharm Theranostics Limited Total Current Liabilities History

Loading

Radiopharm Theranostics Limited vs. peers: Total Current Liabilities Comparison

Loading

Radiopharm Theranostics Limited Total Current Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Radiopharm Theranostics Limited (RADX) FAQ

Radiopharm Theranostics Limited (RADX) currently reports a total current liabilities of $19M as of June 2026. Use the charts on this page to explore Radiopharm Theranostics Limited's total current liabilities history and peer comparisons.

Radiopharm Theranostics Limited reported $19M in total current liabilities as of June 2026. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $19M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Radiopharm Theranostics Limited, and consider following RADX for alerts when major investors trade the stock.

Radiopharm Theranostics Limited is classified in the Healthcare sector. On total current liabilities, it currently shows $19M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing RADX with unrelated industries.